Literature DB >> 29042973

The efficacy of microsurgery in the treatment of cerebral aneurysm rupture and its effect on NF-κB, MCP-1 and MMP-9.

Xintong Zhang1,2, Lei Chen3, Feng Zheng4,5, Yanli Du1.   

Abstract

The clinical efficacy of microsurgical neck clipping for the treatment of cerebral aneurysm rupture and its effect on serum nuclear factor κ-light-chain-enhancer of activated β cells (NF-κB), monocyte chemoattractant protein-1 (MCP-1) and matrix metalloproteinase-9 (MMP-9) levels were investigated. A total of 56 patients with first occurrence of cerebral aneurysm rupture were enrolled from June 2015 to June 2016. These patients were divided into control (25 patients) and observation groups (31 patients) according to treatment received. The patients in the control group were treated with interventional embolization and extraventricular drainage, while the patients in the observation group were treated with microsurgical neck clipping. Serum NF-κB, MCP-1 and MMP-9 levels were measured by ELISA prior to the operation and at 6 h post-operation. Clinical effects were compared at the 6-month follow-up. There was no significant difference in the success rate of the operation between the two groups (p>0.05). The incidence of complications in the observation group was significantly lower than that in the control group (p<0.05). The Glasgow Outcome Scale score was significantly improved in the observation group (p<0.05) compared with the control group. Serum NF-κB, MMP-9 and MCP-1 were significantly decreased in both groups at 6 and 24 h after operation, but the observational group showed significantly lower levels for all three proteins than the control group (p<0.05). The application of early microsurgical neck clipping for the treatment of cerebral aneurysm rupture can reduce complications and improve clinical prognosis, and this may be related to a decrease in serum inflammatory response-related factors (NF-κB and MCP-1) and MMP-9.

Entities:  

Keywords:  MMP-9; NF-κB; cerebral aneurysm; interventional embolization; microsurgery; monocyte chemoattractant protein-1

Year:  2017        PMID: 29042973      PMCID: PMC5639380          DOI: 10.3892/etm.2017.4928

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


Introduction

Cerebral aneurysm is the main cause of spontaneous subarachnoid hemorrhage (SAH), with an incidence of rupture of approximately 1–5%, which is only lower than the incidence of hypertensive intracerebral hemorrhage and cerebral thrombosis. The 30-day mortality rate is as high as 45 and 30% of survivors have moderate to severe neurological dysfunction (1). Studies have shown that chronic inflammation and pathological remodeling of the extracellular matrix may be an important cause of aneurysm (2). The elastic protease infusion-induced experimental animal aneurysm model is similar to human aneurysms at both morphological and pathological levels (3). Studies on abdominal aortic aneurysms have shown that the infiltration of various inflammatory cells can especially promote the secretion of matrix metalloproteinases (MMPs). MMP-9, which in turn accelerates the degradation of elastic and collagen fibers in the arterial wall (4). Nuclear factor-κB (NF-κB) can regulate the expression of a variety of genes involved in the inflammatory response (5). Monocyte chemoattractant protein-1 (MCP-1) is a member of the chemokine CC subfamily and one of the monocyte-macrophage inducing chemokines. As a downstream target protein of NF-κB, MCP-1 plays a role in inducing the inflammatory cascade. There is no common understanding on the surgical timing and surgical methods used for the treatment of acute cerebral aneurysm rupture. Traditional treatment methods include decompressive craniotomy, paracentesis and interventional embolization. Early microsurgical neck clipping can significantly reduce the incidence of rupture and prevent postoperative cerebral vasospasm (6). Early microsurgical neck clipping has a positive effect in cases of high-risk aneurysm rupture (7). The present study further evaluated whether the effect of microsurgery in the treatment of cerebral aneurysm rupture was associated with changes in the serum levels of NF-κB, MCP-1 and MMP-9.

Patients and methods

Patient information

A total of 56 patients with first occurrence of cerebral aneurysm rupture were continuously selected from June 2015 to June 2016. Emergency surgery indications were detected in the patients by CTA examination. This study was approved by the Ethics Committee of the Second Affiliated Hospital of Soochow University. Signed written informed consents were obtained from the patients and/or guardians. Exclusion criteria were: Presence of combined brain tumor, cerebral vascular malformations, arteriovenous fistula and hypertensive intracerebral hemorrhage; presence of serious disturbance of consciousness, intracranial space-occupying lesion, serious condition and expected survival time <24 h; and presence of other underlying diseases which may affect the results. The patients were divided into control (25 patients) and observation groups (31 patients) based on treatment received. The two groups were equivalent regarding key baseline characteristics (Table I).
Table I.

Comparison of baseline characteristics.

CharacteristicsControl group (n=25)Observation group (n=31)t/χ2P-value
Sex (male/female)13/1216/150.0010.977
Age (years)52.6±9.553.3±8.70.0960.924
Onset time (h)10.2±3.512.1±3.60.3250.768
Hypertension (cases, %)6 (24.0)8 (25.8)0.0240.877
Diabetes (cases, %)4 (16.0)6 (19.4)0.0001.000
Hunt-Hess grading (cases, %)0.1190.730
  Level I–II7 (28.0)10 (32.3)
  Level III–V18 (72.0)21 (67.7)
Bleeding site (cases, %)0.0180.991
  Anterior communicating artery12 (48.0)15 (48.4)
  Posterior communicating artery6 (24.0)7 (22.6)
  Middle cerebral artery7 (28.0)9 (29.0)
Aneurysm diameter (mm)8.8±1.68.7±1.50.1520.867
Intracerebral hematoma (cases, %)8 (32.0)13 (41.9)0.5830.445
Cerebroventricular haemorrhage (cases, %)6 (24.0)8 (25.8)0.0240.877

Methods

In accordance with standard medical practices, the operations and procedures were performed by the same surgical and nursing team. Control group patients were treated with interventional embolization and extraventricular drainage. Intracranial pressure and blood pressure were controlled with gastrointestinal bleeding and cerebral vasospasm was prevented prior to surgery. General anesthesia was induced and the Seldinger technique was used to puncture the femoral artery. The bilateral internal carotid artery and vertebral artery were subjected to DSA examination. With the assistance of a microguide wire, the appropriate type of micro-coil was sent to complete the embolization. Embolization was confirmed by angiography. Patients with intracranial hematoma and ventricular hemorrhage were treated with extraventricular drainage. The patients in the observation group were treated with microsurgical neck clipping. A Zeiss OPMI Pentero surgical microscope (E-Maxdent Co., Ltd., Beijing, China) and supporting equipment were used and the pterional approach was applied. The lateral scapula arachnoid and nearby blood vessels were carefully separated to fully expose the circle of Willis. The target vessel was separated and the neck of the tumor was completely clipped. No active bleeding was found after releasing the temporary blocking clip, indicating success of the procedure. To ensure tumor artery flow, a drainage tube was indwelled in the carotid cistern.

Observational index

The success and complication rates were compared between the two groups during a 6-month follow-up period. The Glasgow Outcome Scale (GOS) was used for scoring, and was defined as: Five points, patients recovered and returned to normal condition with mild defects; 4 points, with mild disability, patients could live independently and work under protection; 3 points, sober patients with severe disability, care is needed for daily life; 2 points, vegetative state with minimal response; and 1 point, death. The serum levels of NF-κB, MMP-9 and MCP-1 were measured by ELISA prior to surgery and at 6 and 24 h after surgery. The reagents were obtained from Beyotime Institute of Biotechnology (Jiangsu, China). The microplate reader was purchased from Bio-Rad Laboratories, Inc. (Hercules, CA, USA). The operations were performed in strict accordance with the manufacturer's instructions. The experiments were performed three times and the average value was calculated.

Statistical analysis

Statistical analysis was performed using SPSS 20.0 statistical software (SPSS Inc., Chicago, IL, USA). Measurement data were expressed as mean ± standard deviation (mean ± SD), and comparison between groups was made using independent-samples t-test. Serum levels of NF-κB, MMP-9 and MCP-1 at different time-points were compared using repeated measure analysis of variance (ANOVA). Count data are expressed as cases or %, and comparison between groups was performed using χ2 test. Ranking data were compared using the rank-sum test. P<0.05 was considered to indicate a statistically significant difference.

Results

Surgery success rate and complication incidence

There was no significant difference in the success rate between the two groups (p>0.05). The incidence of complications in the observation group was lower than that in the control group (p<0.05; Table II).
Table II.

Surgery success rate and complication incidence (cases, %).

Complication incidence

GroupsSuccess rateRebleedingCerebrovascular spasmInfectionCerebrospinal fluid leakageTotal
Control (n=25)24 (96.0)2 (8.0)5 (20.0)1 (4.0)1 (4.0)9 (36.0)
Observation (n=31)28 (90.3)1 (3.2)2 (6.5)01 (3.2)4 (12.9)
χ20.0894.142
P-value0.7660.042

GOS score

The GOS score of the observation group was significantly improved compared to the control group (p<0.05; Table III).
Table III.

GOS score (cases, %).

Groups5 points4 points3 points2 points1 point
Control (n=25)8 (32.0)11 (44.0)4 (16.0)1 (4.0)1 (4.0)
Observation (n=31)19 (61.3)8 (25.8)2 (6.5)1 (3.2)1 (3.2)
χ2−2.073
P-value0.038

GOS, Glasgow Outcome Scale.

Serum NF-κB, MMP-9 and MCP-1 levels

Serum NF-κB, MMP-9 and MCP-1 levels in both groups were decreased at 6 and 24 h post-surgery. Observation group levels were lower for the 3 proteins than control group levels (p<0.05; Figs. 1–3).
Figure 1.

Serum NF-κB levels in the control and observation groups pre- and post-surgery. Serum NF-κB levels in both groups gradually decreased at 6 and 24 h post-surgery, with serum NF-κB levels significantly lower in the observation group (*p<0.05 vs. control group pre-surgery; #p<0.05 vs. observation group pre-surgery). NF-κB, nuclear factor-κB.

Figure 3.

Serum MCP-1 levels in the control and observation groups pre- and post-surgery. Serum MCP-1 levels in both groups gradually decreased at 6 and 24 h post-surgery, with serum MCP-1 levels significantly lower in the observation group (*p<0.05 vs. control group pre-surgery; #p<0.05 vs. observation group pre-surgery). MCP-1, monocyte chemoattractant protein-1.

Discussion

Studies have shown that the peak period of rebleeding is 4–9 days post-cerebral aneurysm rupture with high mortality rate (8,9). Early surgery is recommended for patients with Hunt-Hess grading levels I and II, but surgical timing for the patients with levels III to V remains controversial. Some scholars believe that early surgery may increase the mortality rate due to unstable condition induction (9). However, with the development of vascular intervention techniques and micro-technology, early (within 72 h) and ultra-early (24 h) surgical treatment has become possible (10). Without the need for craniotomy, interventional embolization only causes small trauma and can be applied to patients with unstable condition. Interventional embolization leads to relatively fewer hemodynamic changes and stress responses, which in turn increases the success rate (11). The main drawback of interventional embolization is the need to accurately assess the distribution of intracranial blood vessels and aneurysms, and surgical failure is mainly due to vessel variation, errors in localizing target vessels, and incomplete embolization (12). The main complications are angiorrhea and vasospasm, which are related to mechanical stimulation and foreign body reactions caused by surgical materials (13). After interventional embolization, the wound should be closed to prevent rebleeding, with hematoma removal, decompressive craniectomy, or extraventricular drainage then performed to stabilize the patient condition (13). After microsurgical neck clipping, aneurysms shrink due to fibrosis and the incidence of rebleeding is low. The use of microscopy provides clear visualization, which is helpful for avoiding the intracranial nerve and vascular injury, reducing bleeding and increasing positioning accuracy (14). In this study, no significant difference was found in surgical success rate between the two groups, while lower complication incidence rates and higher GOS scores were found in the observation group, indicating that early microsurgical neck clipping was safe and effective for the treatment of cerebral aneurysm rupture. In addition, studies have shown that depressurization treatment should not be performed during surgery to reduce the occurrence of postoperative serious complications, such as cerebral infarction (15). Important traffic arteries should not be clipped during surgery to reduce the occurrence of permanent dysfunction (16). Our study showed that serum levels of NF-κB, MMP-9 and MCP-1 in both groups gradually decreased at 6 and 24 h after surgery, with the observation group presenting significantly lower levels of all three proteins. Aneurysm formation is caused by the local expansion of the arterial wall and damage to elastic and collagen fibers (17). MMPs are mainly responsible for the degradation of arterial wall elastin and collagen (17), and inflammatory cells are the main source of MMP-9 in the arterial wall. The aggregation of macrophages in the aneurysm wall is the main intermediate step of the inflammatory response process (18). MCP-1 is a member of the chemokine CC subfamily and is the strongest monocyte-macrophage chemokine (19). Acute aneurysms are often accompanied with increased MCP-1 levels, which is consistent with the degree of inflammatory response. NF-κB is widely involved in the inflammatory response, immune response, cell differentiation, apoptosis and stress responses. NF-κB can bind to the promoter regions of a variety of proinflammatory cytokines and immunomodulatory factors and is key player in the regulation of the expression of proinflammatory genes. After activation, NF-κB is transported into the nucleus to activate the expression of downstream target genes, which in turn induces macrophage aggregation in the aneurysm wall and the degradation of the extracellular matrix (20,21). The changes in indicator protein expression observed in this study demonstrated that microsurgical treatment can significantly reduce the degree of the inflammatory response and reduce the expression level of MMP-9. In conclusion, the application of early microsurgical neck clipping in the treatment of cerebral aneurysm rupture can reduce the incidence of complications and improve clinical prognosis, which may be associated with a decreased serum inflammatory response and reduced expression level of MMP-9. The shortcomings of the study were the small sample size and short follow-up time. In addition, the correlations between the expression levels of NF-κB, MMP-9 and MCP-1 were not analyzed. Further validation is needed.
  21 in total

1.  Applications and Roles of Coil Embolization and/or Clipping in the Treatment of Cerebral Aneurysm.

Authors:  E Sato; Y Konishi; A Shimada; K Komatsubara; H Yazaki; M Fujitsuka; Y Shiokawa
Journal:  Interv Neuroradiol       Date:  2006-06-15       Impact factor: 1.610

2.  Microsurgical clip obliteration of middle cerebral aneurysm using intraoperative flow assessment.

Authors:  Bob S Carter; Christopher Farrell; Christopher Owen
Journal:  J Vis Exp       Date:  2009-09-25       Impact factor: 1.355

3.  Risk of stroke with temporary arterial occlusion in patients undergoing craniotomy for cerebral aneurysm.

Authors:  Sung-Kon Ha; Dong-Jun Lim; Bong-Gil Seok; Se-Hoon Kim; Jung-Yul Park; Yong-Gu Chung
Journal:  J Korean Neurosurg Soc       Date:  2009-07-31

4.  Murine abdominal aortic aneurysm model by orthotopic allograft transplantation of elastase-treated abdominal aorta.

Authors:  Zhenjie Liu; Qiwei Wang; Jun Ren; Carmel Rebecca Assa; Stephanie Morgan; Jasmine Giles; Qi Han; Bo Liu
Journal:  J Vasc Surg       Date:  2014-06-26       Impact factor: 4.268

5.  Matrix metalloproteinase-9 genotype as a potential genetic marker for abdominal aortic aneurysm.

Authors:  Tyler Duellman; Christopher L Warren; Peggy Peissig; Martha Wynn; Jay Yang
Journal:  Circ Cardiovasc Genet       Date:  2012-08-31

6.  Novel high-throughput in vitro model for identifying hemodynamic-induced inflammatory mediators of cerebral aneurysm formation.

Authors:  Kamil W Nowicki; Koji Hosaka; Yong He; Peter S McFetridge; Edward W Scott; Brian L Hoh
Journal:  Hypertension       Date:  2014-09-15       Impact factor: 10.190

7.  Zinc Prevents Abdominal Aortic Aneurysm Formation by Induction of A20-Mediated Suppression of NF-κB Pathway.

Authors:  Ya-Wei Yan; Jun Fan; Shu-Ling Bai; Wei-Jian Hou; Xiang Li; Hao Tong
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

8.  Role of endoscopy in multi-modality monitoring during aneurysm surgery: A single center experience with 175 consecutive unruptured aneurysms.

Authors:  Yasuhiro Yamada; Yoko Kato; Kohei Ishihara; Keisuke Ito; Takafumi Kaito; Mohsen Nouri; Motoki Oheda; Joji Inamasu; Yuichi Hirose
Journal:  Asian J Neurosurg       Date:  2015 Jan-Mar

9.  An operating microscope with higher magnification and higher resolution for cerebral aneurysm surgery: preliminary experience-technical note.

Authors:  Nobuhisa Matsumura; Takashi Shibata; Emiko Hori; Hironaga Kamiyama; Mariko Tani; Soushi Okamoto; Michiya Kubo; Yukio Horie; Shunro Endo; Satoshi Kuroda
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-10-07       Impact factor: 1.742

10.  Surgical management of ruptured small cerebral aneurysm: Outcome and surgical notes.

Authors:  Giovanni Grasso; Giancarlo Perra
Journal:  Surg Neurol Int       Date:  2015-12-08
View more
  4 in total

1.  Noninvasive Vagus Nerve Stimulation Prevents Ruptures and Improves Outcomes in a Model of Intracranial Aneurysm in Mice.

Authors:  Tomoaki Suzuki; Tsubasa Takizawa; Yoshinobu Kamio; Tao Qin; Tomoki Hashimoto; Yukihiko Fujii; Yuichi Murayama; Aman B Patel; Cenk Ayata
Journal:  Stroke       Date:  2019-05       Impact factor: 7.914

Review 2.  Transradial versus transfemoral access for endovascular therapy of intracranial aneurysms: a systematic review and meta-analysis of cohort studies.

Authors:  Xinyue Huang; Yu Xiong; Xiumei Guo; Xiaodong Kang; Chunhui Chen; Hanlin Zheng; Zhigang Pan; Lingxing Wang; Shuni Zheng; Pantelis Stavrinou; Roland Goldbrunner; Lampis Stavrinou; Weipeng Hu; Feng Zheng
Journal:  Neurosurg Rev       Date:  2022-09-21       Impact factor: 2.800

3.  Increased Levels of Serum IL-15 and TNF-β Indicate the Progression of Human Intracranial Aneurysm.

Authors:  Shuzhe Yang; Qingyuan Liu; Junhua Yang; Jun Wu; Shuo Wang
Journal:  Front Aging Neurosci       Date:  2022-06-17       Impact factor: 5.702

4.  Application of three dimensional (3D) curved multi-planar reconstruction images in 3D printing mold assisted eyebrow arch keyhole microsurgery.

Authors:  Sheng-Jun Li; Fang Wang; Wei Chen; Ying Su
Journal:  Brain Behav       Date:  2020-08-14       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.